| The anticariogenic effect of amine fluorides on Streptococcus sobrinus and glucosyltransferase in biofilms S Shani, M Friedman, D Steinberg Caries research 34 (3), 260-267, 2000 | 160 | 2000 |
| Setting priorities for the adoption of health technologies on a national level—the Israeli experience S Shani, MI Siebzehner, O Luxenburg, J Shemer Health Policy 54 (3), 169-185, 2000 | 106 | 2000 |
| Relation between surface activity and antibacterial activity of amine-fluorides S Shani, M Friedman, D Steinberg International journal of pharmaceutics 131 (1), 33-39, 1996 | 40 | 1996 |
| Developing and implementing a model for changing physicians’ prescribing habits–the role of clinical pharmacy in leading the change E Schwartzberg, S Rubinovich, D Hassin, J Haspel, A Ben‐Moshe, ... Journal of clinical pharmacy and therapeutics 31 (2), 179-185, 2006 | 32 | 2006 |
| In vitro assessment of the antimicrobial activity of a local sustained release device containing amine fluoride for the treatment of oral infectious diseases S Shani, M Friedman, D Steinberg Diagnostic microbiology and infectious disease 30 (2), 93-97, 1998 | 24 | 1998 |
| Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel G Ginsberg, S Shani, B Lev Pharmacoeconomics 13, 231-241, 1998 | 18 | 1998 |
| Adverse drug reactions definitions and terminology H Rabinovitz, M Berkowitch, A Golik, S Shani Harefuah 140 (12), 1181-6, 1228, 2001 | 17 | 2001 |
| Regulation of natural medicines in Israel and abroad T Lavy, B Haran, J Shemer, S Shani Harefuah 139 (9-10), 339-44, 408, 407, 2000 | 12 | 2000 |
| The Israeli model for managing the national list of health services in an era of limited resources S Shani, Z Yahalom Law & Policy 24 (2), 133-147, 2002 | 10 | 2002 |
| The Role of the Pharmaceutical Industry in Disseminating Pharmacovigilance Practice in Developing Countries S Shani, Z Yahalom Food & Drug LJ 63, 701, 2008 | 7 | 2008 |
| Promoting medical technologies in the national list of health services: 1995-2000 J Shemer, T Morginstin, A Hammerman, O Luxenburg, S Shani Harefuah 142 (2), 82-86, 2003 | 7 | 2003 |
| Patients' perceptions of drug therapy counseling in Israel. S Shani, T Morginstin, A Hoffman The Israel Medical Association journal: IMAJ 2 (6), 438-441, 2000 | 7 | 2000 |
| Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center E Schwartzberg, S Livny, A Sterenberg, A Troitsa, M Oren, S Shani Harefuah 142 (1), 5-9, 80, 2003 | 5 | 2003 |
| Role of the pharmacist in a modern health care system S Shani, J Shemer Harefuah 138 (4), 327, 2000 | 5 | 2000 |
| Israel hospital pharmaceutical services: a national survey S Livny, A Hammerman, S Shani, J Shemer Harefuah 138 (10), 828-31, 911, 910, 2000 | 4 | 2000 |
| Legal and regulatory aspects of orphan drugs. S Shani, Z Yahalom Pediatric endocrinology reviews: PER 11, 110-115, 2013 | 3 | 2013 |
| The influence of the relationship between physicians and pharmaceutical companies on the patient from the point of view of policy-makers in Israel R Nissanholtz-Gannot, S Shani, S Shvarts Harefuah 149 (11), 688-92, 750, 2010 | 3 | 2010 |
| Herceptin T Morginstin, S Shani, J Shemer Harefuah 138 (6), 459, 2000 | 3 | 2000 |
| Evaluation of amine fluoride-bacteria interactions on an experimental dental plaque model S Shani, M Friedman, D Steinberg JOURNAL OF DENTAL RESEARCH 75, 1879-1879, 1996 | 3 | 1996 |
| Prescribing information for drugs--legal and regulatory implications Z Yahalom, S Shani Harefuah 153 (11), 671-4, 686, 2014 | 2 | 2014 |
